Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • eir

    Tag: eir

    You Searched For "eir"
    Lupin gets USFDA EIR for Nagpur Facility

    Lupin gets USFDA EIR for Nagpur Facility

    Medical Dialogues Bureau13 April 2020 5:32 AM GMT
    Mumbai: Lupin Limited has announced the receipt of the Establishment Inspection Report (EIR) after the closure of the U.S. FDA inspection of its...
    Dr Reddys Labs receives EIR for Nalgonda-based API plant

    Dr Reddy's Labs receives EIR for Nalgonda-based API plant

    Medical Dialogues Bureau11 April 2020 5:33 AM GMT
    New Delhi: Dr Reddy's Laboratories has announced that it has received an establishment inspection report (EIR) from the US health regulator for its...
    Lupin gets USFDA EIR for Aurangabad Facility

    Lupin gets USFDA EIR for Aurangabad Facility

    Medical Dialogues Bureau4 April 2020 8:08 AM GMT
    Mumbai: Pharma major Lupin Limited (Lupin) has announced the receipt of the Establishment Inspection Report (EIR) from the U.S. FDA for its...
    Jubilant gets USFDA EIR for its Solid Dosage facility at Salisbury, Maryland USA

    Jubilant gets USFDA EIR for its Solid Dosage facility at Salisbury, Maryland USA

    Medical Dialogues Bureau2 April 2020 8:48 AM GMT
    Noida: Jubilant Life Sciences Limited, an integrated global Pharmaceutical and Life Sciences Company, has announced that Jubilant Pharma Limited, a...
    Biocon gets USFDA EIR with VAI Classification for its Malaysian Insulin Manufacturing Facility

    Biocon gets USFDA EIR with VAI Classification for its Malaysian Insulin Manufacturing Facility

    Medical Dialogues Bureau1 April 2020 7:14 AM GMT
    Bengaluru: Biocon Sdn Bhd, a subsidiary of Biocon Limited has announced that it has received the Establishment Inspection Report (EIR) from the U.S....
    Strides receives USFDA EIR for KRS Gardens, Bangalore facility

    Strides receives USFDA EIR for KRS Gardens, Bangalore facility

    Medical Dialogues Bureau31 March 2020 8:00 AM GMT
    Bangalore: Strides Pharma Science Limited has announced that it has received the Establishment Inspection Report (EIR) for the inspection conducted by...
    Lupin gets USFDA EIR for Inhalation Research Center, Florida

    Lupin gets USFDA EIR for Inhalation Research Center, Florida

    Medical Dialogues Bureau30 March 2020 9:34 AM GMT
    Coral Springs & Mumbai: Pharma major Lupin Limited (Lupin) has announced the receipt of the Establishment Inspection Report (EIR) from the U.S....
    Strides Pharma gets USFDA EIR for its Bangalore flagship facility

    Strides Pharma gets USFDA EIR for its Bangalore flagship facility

    Medical Dialogues Bureau27 March 2020 5:56 AM GMT
    Bangalore: Strides Pharma has announced that the Company's flagship facility (KRS Gardens) in Bangalore which was inspected by the USFDA in March...
    Alembic Pharma gets USFDA EIR for API Facility at Karakhadi

    Alembic Pharma gets USFDA EIR for API Facility at Karakhadi

    Medical Dialogues Bureau18 March 2020 6:30 AM GMT
    Gujrat: Alembic Pharmaceuticals Limited has announced that it has received Establishment Inspection Report (EIR) from US Food and Drug Administration...
    Alkem Laboratories receives EIR from USFDA for Baddi facility

    Alkem Laboratories receives EIR from USFDA for Baddi facility

    Medical Dialogues Bureau15 March 2020 3:45 AM GMT
    New Delhi: Drug firm Alkem Laboratories on Friday said the US health regulator has issued an establishment inspection report (EIR) for its...
    Centaur Pharma Ambernath facility receives EIR from USFDA

    Centaur Pharma Ambernath facility receives EIR from USFDA

    Farhat Nasim28 Nov 2019 4:00 AM GMT
    Centaur Pharma has now received a formal EIR (Establishment Inspection Report) from USFDA stating the facility is CGMP compliant and the audit outcome...
    Biocon gets EIR from USFDA for Bengaluru biologics unit

    Biocon gets EIR from USFDA for Bengaluru biologics unit

    Medical Dialogues Bureau6 Nov 2019 3:49 AM GMT
    New Delhi: Biopharmaceutical firm Biocon on Tuesday said it has received an establishment inspection report (EIR) from the US health regulator for its...
    Next

    Popular Stories

    • Email: info@medicaldialogues.in
    • Phone: 011 - 4372 0751

    Website Last Updated On : 13 Oct 2022 5:14 AM GMT
    Company
    • About Us
    • Contact Us
    • Our Team
    • Reach our Editor
    • Feedback
    • Submit Article
    Ads & Legal
    • Advertise
    • Advertise Policy
    • Terms and Conditions
    • Privacy Policy
    • Editorial Policy
    • Comments Policy
    • Disclamier

    This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information:

    Search only trustworthy HONcode health websites:

    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2020 Minerva Medical Treatment Pvt Ltd

    © 2020 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X
    X